Agent-Based Modelling Reveals the Role of the Tumor Microenvironment on the Short-Term Success of Combination Temozolomide/Immune Checkpoint Blockade to Treat Glioblastoma
Anudeep Surendran, Adrianne L. Jenner, Elham Karimi, Benoit Fiset, Daniela F. Quail, Logan A. Walsh, Morgan Craig
Topics & Concepts
TemozolomideImmune checkpointMedicineBlockadeOncolytic virusImmunotherapyOncologyGlioblastomaChemotherapyClinical trialGliomaImmune systemDacarbazineRadiation therapyInternal medicineCancer researchImmunologyReceptorGlioma Diagnosis and TreatmentMathematical Biology Tumor GrowthCancer Immunotherapy and Biomarkers